Diabetes - European Medical Journal

Continue

Diabetes

Filter
3 Nov 2015

Transforming Growth Factor Beta-Based Therapies, a Potential Modulator of the Immune Response in Type 1 Diabetes?

Immunobiological interventions are proving to be an exciting new area for mobilising the immune response towards certain tumours.
31 Oct 2014

Investigating the Different Dimensions of DPP-4 Inhibitors

This Takeda-sponsored European Association for the Study of Diabetes (EASD) symposium addressed the pharmacology, clinical use, and future therapeutic…
31 Oct 2014

Diffusion Tensor Imaging Of the Brain in Type 1 Diabetes

Individuals with Type 1 diabetes mellitus (T1DM) are required to carefully manage their insulin dosing, dietary intake, and activity levels in order to…
31 Oct 2014

Detection and Early Lifestyle Intervention in Those at Risk of Type 2 Diabetes

The prevalence of Type 2 diabetes mellitus (T2DM) has reached epidemic proportions in recent years. It is now widely recognised that T2DM…
31 Oct 2014

A Practical Review of Insulin Pen Devices

Since the advent of insulin pens in 1985, there have been ongoing improvements providing several advantages over the traditional vial and syringe method…
31 Oct 2014

Membrane Flexibility and Cellular Energy Management in Type 2 Diabetes, Gestational Diabetes, and Obesity

In the search to understand the onset of life’s biochemistry, scientists attached a great deal of importance to unravelling the replication mechanism of…
31 Oct 2014

Targeting Adipose Tissue Lipid Metabolism to Improve Glucose Metabolism in Cardiometabolic Disease

With Type 2 diabetes mellitus and cardiovascular disease prevalence on the rise, there is a growing need for improved strategies to prevent or treat…
31 Oct 2014

Residual Cardiovascular Risk in Diabetic Patients: The Role of Fibrate Statin Combination

Patients with Type 2 diabetes mellitus (T2DM) have increased cardiovascular disease (CVD) risk. The use of statins significantly reduces the rate of CVD…